Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials

Scritto il 13/04/2026
da Dirk Müller-Wieland

No abstract

Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70752. Online ahead of print.

NO ABSTRACT

PMID:41969169 | DOI:10.1111/dom.70752